These findings are in line with other published work that shows decreased plasma sRAGE in individuals with cognitive impairment, obesity, and IR [26, 30, 37] and further supports the protective role of sRAGE in inflammatory diseases. This evidence concerns the gene AGER and obesity due to melanocortin 4 receptor deficiency.